Mesothelin Expression in Triple Negative Breast Carcinomas Correlates Significantly with Basal-Like Phenotype, Distant Metastases and Decreased Survival
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mesothelin Expression in Triple Negative Breast Carcinomas Correlates Significantly with Basal-Like Phenotype, Distant Metastases and Decreased Survival
Authors
Keywords
Breast tumors, Cloning, Carcinomas, Cell staining, Metastasis, Invasive ductal carcinoma, Invasive lobular carcinoma, Lymph nodes
Journal
PLoS One
Volume 9, Issue 12, Pages e114900
Publisher
Public Library of Science (PLoS)
Online
2014-12-16
DOI
10.1371/journal.pone.0114900
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mesothelin Expression and Survival Outcomes in Triple Receptor Negative Breast Cancer
- (2013) Napa Parinyanitikul et al. Clinical Breast Cancer
- Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated with Reduced Recurrence-Free and Overall Survival in Early-Stage Lung Adenocarcinoma
- (2013) S. S. Kachala et al. CLINICAL CANCER RESEARCH
- Mesothelin, a novel immunotherapy target for triple negative breast cancer
- (2012) Julia Tchou et al. BREAST CANCER RESEARCH AND TREATMENT
- Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer
- (2012) T Einama et al. BRITISH JOURNAL OF CANCER
- Tissue and Serum Mesothelin Are Potential Markers of Neoplastic Progression in Barrett's Associated Esophageal Adenocarcinoma
- (2012) N. P. Rizk et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Coexpression of MUC16 and mesothelin is related to the invasion process in pancreatic ductal adenocarcinoma
- (2012) Atsushi Shimizu et al. CANCER SCIENCE
- Mesothelin Overexpression Promotes Mesothelioma Cell Invasion and MMP-9 Secretion in an Orthotopic Mouse Model and in Epithelioid Pleural Mesothelioma Patients
- (2012) E. L. Servais et al. CLINICAL CANCER RESEARCH
- Mesothelin-Targeted Agents in Clinical Trials and in Preclinical Development
- (2012) R. J. Kelly et al. MOLECULAR CANCER THERAPEUTICS
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers
- (2012) Jordan M. Winter et al. PLoS One
- Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor
- (2011) E. K. Moon et al. CLINICAL CANCER RESEARCH
- A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction
- (2011) D. T. Le et al. CLINICAL CANCER RESEARCH
- Mesothelin and GPR30 Staining Among a Spectrum of Pancreatic Epithelial Neoplasms
- (2011) Joseph P. Glass et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- Mesothelin expression correlates with prolonged patient survival in gastric cancer
- (2011) Kenji Baba et al. JOURNAL OF SURGICAL ONCOLOGY
- Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression
- (2011) Uddalak Bharadwaj et al. Molecular Cancer
- Triple-Negative Breast Cancer: An Unmet Medical Need
- (2011) C. A. Hudis et al. ONCOLOGIST
- Molecular Stratification of Triple-Negative Breast Cancers
- (2011) C. M. Perou ONCOLOGIST
- Co-Expression of Mesothelin and CA125 Correlates With Unfavorable Patient Outcome in Pancreatic Ductal Adenocarcinoma
- (2011) Takahiro Einama et al. PANCREAS
- Triple Negative Breast Cancer: Outcome Correlation With Immunohistochemical Detection of Basal Markers
- (2010) Aye Aye Thike et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Phase I Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody MORAb-009 in Patients with Mesothelin-Expressing Cancers
- (2010) R. Hassan et al. CLINICAL CANCER RESEARCH
- Deconstructing the molecular portraits of breast cancer
- (2010) Aleix Prat et al. Molecular Oncology
- Phase I Trial of Continuous Infusion Anti-Mesothelin Recombinant Immunotoxin SS1P
- (2009) R. J. Kreitman et al. CLINICAL CANCER RESEARCH
- Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
- (2009) E. A. Rakha et al. CLINICAL CANCER RESEARCH
- Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer
- (2009) Aye Aye Thike et al. MODERN PATHOLOGY
- Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
- (2009) C. Carpenito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- How basal are triple-negative breast cancers?
- (2008) François Bertucci et al. INTERNATIONAL JOURNAL OF CANCER
- Mesothelin-Induced Pancreatic Cancer Cell Proliferation Involves Alteration of Cyclin E via Activation of Signal Transducer and Activator of Transcription Protein 3
- (2008) U. Bharadwaj et al. MOLECULAR CANCER RESEARCH
- Triple-negative/basal-like breast cancer: review
- (2008) Emad A. Rakha et al. PATHOLOGY
- Mesothelin targeted cancer immunotherapy
- (2007) Raffit Hassan et al. EUROPEAN JOURNAL OF CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started